Expanding the arsenal: metformin for the treatment of triple-negative breast cancer?

Cell Cycle. 2009 Sep 1;8(17):2681. doi: 10.4161/cc.8.17.9502. Epub 2009 Sep 1.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Apoptosis
  • Breast Neoplasms / drug therapy*
  • ErbB Receptors / metabolism
  • Female
  • Humans
  • Metformin / pharmacology*
  • Metformin / therapeutic use
  • Signal Transduction

Substances

  • Antineoplastic Agents
  • Metformin
  • ErbB Receptors
  • AMP-Activated Protein Kinases